Effects of Depression and Selective Serotonin Reuptake Inhibitor Use on Adherence to Highly Active Antiretroviral Therapy and on Clinical Outcomes in HIV-Infected Patients
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To determine the impact of depression on highly active antiretroviral therapy (HAART) adherence and clinical measures and investigate if selective serotonin reuptake inhibitors (SSRIs) improve these measures. DESIGN: Retrospective cohort study. METHODS: In 2 large health maintenance organizations, we measured the effects of depression (with and without SSRI use) on adherence and changes in viral and immunologic control among HIV-infected patients starting a new HAART regimen. HAART adherence, HIV RNA levels, and changes in CD4 T-cell counts through 12 months were measured. RESULTS: A total of 3359 patients were evaluated; 42% had a depression diagnosis, and 15% used SSRIs during HAART. Depression without SSRI use was associated with significantly decreased odds of achieving > or =90% adherence to HAART (odds ratio [OR] = 0.81, 95% confidence interval [CI]: 0.70 to 0.98; P = 0.03). Depression was associated with significantly lower odds of an HIV RNA level <500 copies/mL (OR = 0.77, 95% CI: 0.62 to 0.95; P = 0.02). Depressed patients compliant with SSRI medication (>80% adherence to SSRI) had HAART adherence and viral control statistically similar to nondepressed HIV-infected patients taking HAART. Comparing depressed with nondepressed HIV-infected patients, CD4 T-cell responses were statistically similar; among depressed patients, those compliant with SSRI had statistically greater increases in CD4 cell responses. CONCLUSIONS: Depression significantly worsens HAART adherence and HIV viral control. Compliant SSRI use is associated with improved HIV adherence and laboratory parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289
Krieger, N. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,654
Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., et al. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.721 · Cited by 1,255 · cited 1×
“30% in some studies in HIV-infected patients.(28,29) It is conceivable that SSRI use, which is commonly prescribed in this population, might improve HAART adherence by improving mood and treating any underlying depression and/or anxiety.”
BackgroundCatz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000) · Health Psychology · doi:10.1037//0278-6133.19.2.124 · Cited by 685
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
Gordillo, V., del Amo, J., Soriano, V., & González-Lahoz, J. (1999) · AIDS · doi:10.1097/00002030-199909100-00021 · Cited by 658
Bangsberg, D. R. (2006) · Clinical Infectious Diseases · doi:10.1086/507526 · Cited by 534
Estimating medication persistency using administrative claims data.
Sikka, R., Xia, F., & Aubert, R. E. (2005) · PubMed · Cited by 500
Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., Vecchiet, J., Monforte, A. D., Wu, A. W., & Antinori, A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00007 · Cited by 480
Steiner, J. F., Koepsell, T. D., Fihn, S. D., & Inui, T. S. (1988) · Medical Care · doi:10.1097/00005650-198808000-00007 · Cited by 458
Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity
Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., Thrasher, D., Goetz, M. B., & Stefaniak, M. (2002) · Neurology · doi:10.1212/01.wnl.0000038347.48137.67 · Cited by 455
Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F.-Y., & Gifford, A. L. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00093-7 · Cited by 398
Depressive Symptoms and AIDS-Related Mortality Among a Multisite Cohort of HIV-Positive Women
Cook, J. A., Grey, D., Burke, J., Cohen, M. H., Gurtman, A. C., Richardson, J. L., Wilson, T. E., Young, M. A., & Hessol, N. A. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.7.1133 · Cited by 396
Descamps, D. (2000) · JAMA · doi:10.1001/jama.283.2.205 · Cited by 367
HIV disease progression: depression, stress, and possible mechanisms
Leserman, J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00323-8 · Cited by 307
Yun, L. W. H., Maravi, M., Kobayashi, J. S., Barton, P. L., & Davidson, A. J. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000147524.19122.fd · Cited by 283
Lima, V. D., Geller, J., Bangsberg, D. R., Patterson, T. L., Daniel, M., Kerr, T., Montaner, J. S., & Hogg, R. S. (2007) · AIDS · doi:10.1097/qad.0b013e32811ebf57 · Cited by 275
Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., d’Arminio Monforte, A., Wu, A. W., & Starace, F. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.5.394 · Cited by 275
Hunt, P. W., Deeks, S. G., Rodriguez, B., Valdez, H., Shade, S. B., Abrams, D. I., Kitahata, M. M., Krone, M., Neilands, T. B., Brand, R. J., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00009 · Cited by 273
Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy
Starace, F., Ammassari, A., Trotta, M. P., Murri, R., De Longis, P., Izzo, C., Scalzini, A., Monforte, A. D., Wu, A. W., & Antinori, A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00010 · Cited by 253
Adherence of Human Immunodeficiency Virus–Infected Patients to Antiretroviral Therapy
Singh, N., Berman, S. M., Swindells, S., Justis, J. C., Mohr, J. A., Squier, C., & Wagener, M. M. (1999) · Clinical Infectious Diseases · doi:10.1086/520443 · Cited by 248
Mugavero, M., Ostermann, J., Whetten, K., Leserman, J., Swartz, M., Stangl, D., & Thielman, N. (2006) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.20.418 · Cited by 220
Antiretroviral adherence interventions: a review of current literature and ongoing studies.
Simoni, J. M., Frick, P. A., Pantalone, D. W., & Turner, B. J. (2003) · PubMed · Cited by 219
Adherence to Antiretroviral Therapy by Human Immunodeficiency Virus–Infected Patients
Turner, B. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/340197 · Cited by 194
the MANIF 2000 Study Group, Bouhnik, A.-D., Préau, M., Vincent, E., Carrieri, M. P., Gallais, H., Lepeu, G., Gastaut, J.-A., Moatti, J.-P., & Spire, B. (2005) · Antiviral Therapy · doi:10.1177/135965350501000103 · Cited by 182
Older Age and the Response to and Tolerability of Antiretroviral Therapy
Silverberg, M. J. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.684 · Cited by 173
Self-citationCantrell, C. R., Eaddy, M. T., Shah, M. B., Regan, T. S., & Sokol, M. C. (2006) · Medical Care · doi:10.1097/01.mlr.0000204287.82701.9b · Cited by 166
Rabkin, J. G., Wagner, G. J., & Rabkin, R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.101 · Cited by 142
Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS
Israelski, D. M., Prentiss, D. E., Lubega, S., Balmas, G., Garcia, P., Muhammad, M., Cummings, S., & Koopman, C. (2007) · AIDS Care · doi:10.1080/09540120600774230 · Cited by 137
Elliott, A. J., Uldall, K. K., Bergam, K., Russo, J., Claypoole, K., & Roy-Byrne, P. P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.3.367 · Cited by 122
Kitahata, M. M., Reed, S. D., Dillingham, P. W., Rompaey, S. E. V., Young, A. A., Harrington, R. D., & Holmes, K. K. (2004) · International Journal of STD & AIDS · doi:10.1258/0956462042563666 · Cited by 113
Goldie, S. J., Paltiel, A. D., Weinstein, M. C., Losina, E., Seage, G. R., Kimmel, A. D., Walensky, R. P., Sax, P. E., & Freedberg, K. A. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.007 · Cited by 103
Fairley, C. K., Permana, A., & Read, T. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00322.x · Cited by 92
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS
Ferrando, S. J., Goldman, J. D., & Charness, W. E. (1997) · General Hospital Psychiatry · doi:10.1016/s0163-8343(96)00172-7 · Cited by 91
Treatment-Related Factors and Highly Active Antiretroviral Therapy Adherence
Trotta, M. P., Ammassari, A., Melzi, S., Zaccarelli, M., Ladisa, N., Sighinolfi, L., Mura, M. S., Monforte, A. D., & Antinori, A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00008 · Cited by 79
Depression and HIV Infection: Impact on Immune Function and Disease Progression
Cruess, D. G., Petitto, J. M., Leserman, J., Douglas, S. D., Gettes, D. R., Ten Have, T. R., & Evans, D. L. (2003) · CNS Spectrums · doi:10.1017/s1092852900023452 · Cited by 70
Schwartz, J. A. J., & McDaniel, J. S. (1999) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1999)9:2<70::aid-da4>3.0.co;2-l · Cited by 35
Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs)
Keene, M. S., Eaddy, M. T., Mauch, R. P., Regan, T. S., Shah, M. B., & Chiao, E. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x65420 · Cited by 21
Practical psychopharmacology in HIV-1 and acquired immunodeficiency syndrome
Robinson, M. J., & Qaqish, R. B. (2002) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00056-x · Cited by 16
Depression comes in many disguises to the providers of primary care: recognition and management.
Schuyler, D. (2000) · PubMed · Cited by 12
Predictors of Virologic Success in Patients Completing a Structured Antiretroviral Adherence Program
Defino, M., Clark, J. L., Mogyoros, D., & Shuter, J. (2004) · Journal of the Association of Nurses in AIDS Care · doi:10.1177/1055329004269135 · Cited by 11
Cited by
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P., Anderson, J. R., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 837
Shippee, N. D., Shah, N. D., May, C. R., Mair, F. S., & Montori, V. M. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.05.005 · Cited by 728
Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 496
Self-citation
Metadata
- Authors
- Horberg, M. A., Silverberg, M. J., Hurley, L. B., Towner, W. J., Klein, D. B., Bersoff-Matcha, S., Weinberg, W. G., Antoniskis, D., Mogyoros, M., Dodge, W. T., Dobrinich, R., Quesenberry, C. P., & Kovach, D. A.
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2008-03-01
- Volume
- 47
- Issue
- 3
- Pages
- 384-390
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W2153046918
- Cited by
- 264
- References
- 40
- FWCI
- 11.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.